Loading clinical trials...
Loading clinical trials...
Improving Glycemic Control and Clinical Outcomes in Insulin Treated DM2 Patients Managed with CGM Devices and Clarity, a Randomized Clinical Trial
Conditions
Interventions
Continuous glucose Monitoring Devices and Clarity Software
Point of Care (POC) blood glucose
Locations
1
United States
Baltimore VA Medical Center
Baltimore, Maryland, United States
Start Date
November 22, 2024
Primary Completion Date
November 22, 2024
Completion Date
November 22, 2024
Last Updated
November 26, 2024
NCT07224321
NCT07222137
NCT07536516
NCT07232537
NCT07340320
NCT06513026
Lead Sponsor
University of Maryland, Baltimore
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions